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Summary
Leiomyomas are one of the rarest neoplasms of the breast. Intraparenchymal leiomyomas can present a diagnostic 
challenge, as they can resemble other benign, and more importantly, malignant lesions - especially leiomyosarcomas. Here 
we report a case of a 28-year old female patient with a palpable mass in the right upper quadrant of the right breast and 
present diagnostic and histopathological features, with special reference to magnetic resonance imaging.
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PRIKAZ SLUČAJA RIJETKOG UNUTARPARENHIMNOG LEIOMIOMA DOJKE  
– DIJAGNOSTIČKE I PATOHISTOLOŠKE ZNAČAJKE
Sažetak
Leiomiomi su izrazito rijetki tumori dojke. Unutarparenhimni leiomiomi predstavljaju dijagnostički izazov, jer mogu 
nalikovati na druge dobroćudne i zloćudne tvorevine, posebice na leiomiosarkom. U radu je prikazan slučaj 28-godišnje 
žene s opipljivom masom u desnoj gornjoj četvrtini desne dojke. Opisane su dijagnostičke i patohistološke značajke nađe-
nog tumora, s posebnim osvrtom na magnetsku rezonanciju.
KLJUČNE RIJEČI: tumori dojke, leiomiom, tumor glatkih mišića, magnetska rezonancija, diferencijalna dijagnoza
INTRODUCTION
Leiomyoma is a smooth muscle tumor, fre-
quently found in the gastrointestinal and female 
reproductive organs, especially uterus (1). Due to 
its origin, leiomyoma is one of the rarest neo-
plasms of the breast. There are currently two sub-
groups - more frequent, superficial or subareolar 
leiomyomas, and more infrequent, intraparenchy-
mal leiomyomas (2). We will report a rare case of 
breast intraparenchymal leiomyoma along with 
diagnostic and histopathologic features.
CASE REPORT
A 28-year old female patient with a palpable 
mass in her right breast presented in our surgical 
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outpatient clinic. On physical examination, the 
firm lesion was on the border of the upper quad-
rants of the right breast. The diameter of the lesion 
was around 2 cm, and the distance from the nipple 
was 7 cm. Axillary lymph nodes were not en-
larged. Despite the positive history of familial 
breast cancer (both grandmothers at the age of 60), 
this was her first visit to a physician for a breast 
check-up.
Ultrasonography (US) of the right breast 
showed a 1,5 cm sized, circumscribed, oval, hy-
poechoic structure (Fig.1). There was a suspicious 
dense cyst on the initial examination, but given 
the age of the patient and her positive family his-
tory of breast cancer, the cytological examination 
was performed. The result of fine-needle aspira-
tion (FNA) was consistent with a mesenchymal 
tumor. After that, the patient was referred for a 
magnetic resonance (MR) imaging of the breast. 
The breast magnetic resonance imaging (MRI) 
showed the mass on the border of the upper quad-
rants of the right breast, measuring 2.2cm in the 
longest diameter. The mass was isointense with 
surrounding tissue on pre-contrast T1-weighted 
sequences (Fig. 2a), and it was of the high intensi-
ty on short tau inversion recovery (STIR) sequence 
(Fig. 2b).
At subtraction sequences, the mass showed 
intense postcontrast enhancement, somewhat het-
erogeneous in the middle, but with progressive 
enhancement pattern, which in most cases indi-
cates benign mass on MRI scans (Fig. 2c). There-
fore, the MRI, in this case, was not conclusive of 
benignity. There were no other signs of postcon-
trast enhancement in both breasts on the MRI 
scan. The mass was assessed as breast imaging re-
porting and data system (BIRADS) 4 category. 
The lymph nodes in both axillary regions were 
described as reactive, benign lymph nodes, both 
on US and MR examinations.
We referred the patient to open surgical biop-
sy to confirm the diagnosis. The tumor with around 
1cm of the surrounding tissue was resected.
Histopathological analysis of the specimen 
revealed a well-circumscribed, rubbery white tu-
mor with a white whorled cut surface, in the mid-
dle of the resected breast tissue. The diameter of 
the tumor was 1.7 cm, with free resection margins. 
Histologically, it consisted of interlacing fascicles 
of spindle-shaped cells with oval nuclei without 
mitotic figures, cell atypia or necrosis (Fig. 3a). Im-
munohistochemical analysis showed strong dif-
Figure 1. Breast ultrasonography shows a 1,5 cm sized hypo­
echoic lesion with circumscribed margins.
Figure 2c. On subtraction sequences  
the lesion shows intense postcontrast 
enhancement.
Figure 2a. The T1­weighted axial MRI 
shows an isointense lesion.




fuse positivity for smooth-muscle actin (Dako, 
Clone 1A4) and strong focal positivity for desmin 
(Dako, Clone D33) (Fig. 3b). According to histolo-
gy and immunohistochemical results, the tumor 
was a leiomyoma of the breast.
DISCUSSION
Leiomyomas are benign non-epithelial tu-
mors, described as benign spindle cell lesions, 
nonspecific to mammary stroma (3). While sub-
areolar leiomyomas are a common finding in both 
sexes, intraparenchymal type of leiomyomas rare-
ly occurs middle-aged women (4). They were de-
scribed in approximately 30 cases so far, with only 
one case in men (5). Although there are various 
theories, the etiology of deep parenchymal leio-
myomas is still undetermined. It is most likely 
that smooth muscle cells, which form the tumor, 
originate from the walls of mammary blood ves-
sels. Alternatively, smooth muscle lesions in the 
breast could form from the teratoid origin, from a 
multipotent mesenchymal cell, angiomatous 
smooth muscle, or myoepithelial cells of breast 
ducts (6).
Clinically, intraparenchymal leiomyomas of 
the breast appear as painless, firm, and mobile 
nodules, with well-defined borders and variable 
size (7). Their slow growth is consistent with their 
benign nature.
The diagnostic approach mostly includes 
mammography, sonography, needle-core biopsy, 
and, as in our case, magnetic resonance imaging. 
Leiomyomas usually appear as well-circum-
scribed lesions on mammography and ultraso-
nography. On mammography, the lesion is either 
isodense or hyperdense with no radial extensions, 
and no microcalcification (6,8). Sonographic crite-
ria are nonspecific and include hypoechoic lesion 
with or without decreased posterior acoustic 
shadowing (9,10). Minami et al reported the first 
case of intraparenchymal leiomyoma evaluated 
by MRI. They noticed that these lesions can be di-
vided into degenerative and nondegenerative 
forms using MRI, but that the MRI is inconclusive 
in terms of distinguishing between malignant and 
benign entities and/or type of degeneration (11). 
Our findings on MR scans correspond to features 
of leiomyomas arising elsewhere in the body.
The benign breast lesions remain underrecog-
nized, which makes it even more essential to dif-
ferentiate them from more aggressive and malig-
nant entities (3). Since leiomyomas show similar 
clinical and radiologic features as other benign 
and/or malignant diseases of the breast, a thorough 
 histological and immunohistochemical analysis 
should be administered (12). Differential diagnosis 
of intraparenchymal leiomyoma includes numer-
ous other lesions: myofibroblastoma, fibromatosis, 
phyllodes tumors, benign spindle cell tumor, spin-
dle cell myoepithelioma, fibroadenoma, adeno-
myoepithelioma. Nevertheless, differentiating leio-
myoma from leiomyosarcoma is of great impor-
tance (2,4,13). Leiomyosarcoma is a malignant 
Figure 3a. Histopathologic analysis of the specimen shows inter­
lacing fascicles of spindle­shaped cells with oval nuclei. Magnifi­
cation 50x.
Figure 3b. Immunohistochemical analysis shows diffuse positiv­




smooth muscle tumor with a predisposition for lo-
cal recurrence and distal spreading and represents 
a diagnostic challenge in the evaluation of smooth 
muscle tumors (14). Histopathological analysis of 
suspected lesion is the only way to differentiate 
leiomyomas and leiomyosarcomas. The absence of 
cell atypia, mitosis, vascular invasion, and necrosis 
favors the benign nature of the lesion (14).
The treatment of choice for intraparenchymal 
leiomyomas is excision with free margins. Con-
trary to leiomyosarcoma, no tendency for local re-
currence or distal spreading is seen (9).
CONCLUSION
Intraparenchymal leiomyomas are one of the 
rarest described neoplasms of the breast. The lack 
of specific radiologic features and a wide range of 
differential diagnoses, which include not only be-
nign breast lesions but, more importantly, aggres-
sive and malignant entities, makes it difficult to 
establish an accurate diagnosis. The only definite 
diagnostic method is the histological evaluation of 
the lesion. The presented case is the second re-
ported case of leiomyoma of the breast recognized 
on MRI. In our opinion, MRI is of great value for 
the diagnosis and evaluation of benign breast le-
sions, as it can detect and characterize small le-
sions and provide essential information for ade-
quate treatment and follow-up.
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